HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearchCompany Lookup
The Week

Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey

A survey of 36 U.S. gastroenterologists found that significant treatment gaps remain in the growing IBD drug market despite an expanding range of therapies.

By FiercePharma · Jul 25, 2026 · via FiercePharma

This is an aggregated industry headline. Read the full story at FiercePharma →

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback
As outside experts gathered for a second day to discuss adding certain popular-yet-unapproved peptides to the …
Jul 26, 2026
The WeekFierceBiotech ↗
Fierce Biotech Layoff Tracker 2026: Amgen sheds staff; Clinuvel cuts fifth of workforce
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial tea…
Jul 26, 2026
Tariffs, Korean biopharma M&A, and a Hong Kong-first IPO signal a more fragmented pharma market
The WeekBriefing
Tariffs, Korean biopharma M&A, and a Hong Kong-first IPO signal a more fragmented pharma market
Three items stood out this week: U.S. import tariffs on generic drugs, Samsung Biologics pursuing a $1.8 billi…
Jul 26, 2026